<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">The Middle East Respiratory Syndrome (MERS) coronavirus (MERS-CoV) [
 <xref rid="bib1" ref-type="bibr">1</xref>] is listed in the 2019 WHO Blueprint priority list of pathogens [
 <xref rid="bib2" ref-type="bibr">2</xref>] because it causes high mortality rates in humans [
 <xref rid="bib3" ref-type="bibr">3</xref>], there are currently no specific treatments or vaccines and it remains a threat to global health security. Since the first identification of the MERS-CoV as a novel zoonotic human pathogen in September 2012 [
 <xref rid="bib4" ref-type="bibr">4</xref>], it continues to circulate in the Middle East causing intermittent community and healthcare associated outbreaks, as well as in returning travelers from the Middle East [
 <xref rid="bib5" ref-type="bibr">5</xref>]As of January 10th, 2020, a total of 2468 laboratory-confirmed cases of MERS-CoV infection, with 851 deaths (34.5% mortality) were reported from 27 countries to the WHO, the majority (2073 cases, 772 deaths) occurred in the Kingdom of Saudi Arabia (KSA) [
 <xref rid="bib1" ref-type="bibr">1</xref>]. Health care associated outbreaks of MERS-CoV are a hallmark of MERS-CoV and they account for approximately 40% of MERS cases reported to date Large outbreaks have occurred in KSA [
 <xref rid="bib1" ref-type="bibr">1</xref>,
 <xref rid="bib6" ref-type="bibr">[6]</xref>, 
 <xref rid="bib7" ref-type="bibr">[7]</xref>, 
 <xref rid="bib8" ref-type="bibr">[8]</xref>, 
 <xref rid="bib9" ref-type="bibr">[9]</xref>, 
 <xref rid="bib10" ref-type="bibr">[10]</xref>, 
 <xref rid="bib11" ref-type="bibr">[11]</xref>, 
 <xref rid="bib12" ref-type="bibr">[12]</xref>] and the largest outside KSA occurred in the Republic of Korea (South Korea) in 2015 [
 <xref rid="bib1" ref-type="bibr">1</xref>,
 <xref rid="bib13" ref-type="bibr">13</xref>,
 <xref rid="bib14" ref-type="bibr">14</xref>].
</p>
